GLP-1 Medications for Weight Loss: The Complete Guide
GLP-1 receptor agonists represent the most significant advance in weight loss medicine in decades. Here's everything you need to know about how they work, what to expect, and whether you're a candidate.
Key takeaways
GLP-1 medications reduce hunger, slow digestion, and quiet food cravings — addressing the biological drivers of overeating rather than relying on willpower.
Semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) are the most widely prescribed GLP-1 and GIP/GLP-1 medications.
Clinical trials show average weight loss of 15–21% of body weight over 68–72 weeks.
GLP-1s are generally not appropriate for people with a history of medullary thyroid cancer or MEN 2 syndrome.
What GLP-1 actually stands for
GLP-1 stands for glucagon-like peptide-1 — a hormone naturally produced in your gut after eating. It signals your brain to reduce hunger, tells your pancreas to release insulin in response to glucose, and slows the emptying of your stomach to extend the feeling of fullness.
GLP-1 medications mimic this hormone and amplify its effects. Originally developed to treat type 2 diabetes, these drugs unexpectedly produced substantial weight loss in clinical trials — which led to their development as dedicated weight loss treatments.
How GLP-1 medications produce weight loss
Appetite suppression
GLP-1 receptors in the brain regulate hunger signals. Activation reduces overall appetite and the frequency of hunger sensations.
Reduced food noise
Many patients describe a quieting of the constant background thoughts about food — sometimes called "food noise." This psychological shift is often described as transformative.
Slowed gastric emptying
Food moves more slowly from the stomach into the small intestine, keeping you feeling full for longer after meals.
Improved insulin response
GLP-1 medications improve how the body processes blood sugar, which has downstream effects on energy regulation and fat storage.
GLP-1 medications currently available
| Brand name | Active ingredient | Approved for | Form |
|---|---|---|---|
| Wegovy | Semaglutide | Weight loss | Weekly injection |
| Ozempic | Semaglutide | Type 2 diabetes (off-label for weight) | Weekly injection |
| Rybelsus | Semaglutide | Type 2 diabetes | Daily tablet |
| Zepbound | Tirzepatide | Weight loss | Weekly injection |
| Mounjaro | Tirzepatide | Type 2 diabetes | Weekly injection |
| Saxenda | Liraglutide | Weight loss | Daily injection |
Who may qualify for GLP-1 treatment
GLP-1 medications are typically considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher alongside at least one weight-related health condition — such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea.
They are generally not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. Pregnancy is also a contraindication. A provider will review your complete health history before any prescription is issued.
GLP-1 alternatives to consider
If GLP-1 medications aren't right for you, other prescription options exist. Metformin has modest weight effects with a long safety record. Bupropion and naltrexone combinations can be effective for some patients. Your provider can review the full range of options based on your individual health profile.
† This article is for educational purposes only and does not constitute medical advice. Eligibility for GLP-1 treatment is determined solely by a licensed healthcare provider based on your individual health profile.